A new predictive model for insulin-dependent diabetes mellitus susceptibility based on combinations of molecular HLA-DRB1 and HLA-DQB1 pockets

被引:20
作者
Djoulah, S
Busson, M
Sasazuki, T
Maillere, B
Yasunaga, S
Kimura, A
Charron, D
Hors, J
机构
[1] Dept Immunol, Paris, France
[2] Hosp St Louis, INSERM U396, Paris, France
[3] CEA, Dept Prot Engn, Saclay, France
[4] Tokyo Med & Dent Univ, Tokyo 113, Japan
[5] Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan
[6] Inst Pasteur, Paris, France
来源
TISSUE ANTIGENS | 1999年 / 54卷 / 04期
关键词
type 1 insulin-dependent diabetes mellitus; HLA-DR; HLA-DQ; population study; HLA pockets; peptide; susceptibility prediction;
D O I
10.1034/j.1399-0039.1999.540403.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
With a view to establishing an accurate evaluation of the genetic predisposition to insulin-dependent type I diabetes (IDDM), we have built a model based on the characteristics of the relevant pockets of HLA-DR and -DQ molecules. Three independent populations were investigated. Group I and group II were Caucasoids, while group III was Japanese, including a total of 1,166 IDDM patients and 2,391 healthy controls. We formulate the hypothesis that suceptibility to IDDM is not only explained by the absence of Aspartate 57 (negative charge) from pocket 9 of DQB1 (P9DQ), but also by the presence of an electric charge (+/- vs. neutral), generated by residues 70, 71 and 74 in pockets 4 of DRB1 (P4DR) and DQB1 (P4DQ) molecules. The respective weight of each pocket, was evaluated in a multivariate analysis based on the logistic regression method. The 4 components (2 loci and 2 pockets) were systematically analysed in the computer model. It was clearly shown that the structural characteristics of pockets P9DQ-P4DR and, to a lesser degree that of P4DQ, account for IDDM predisposition. On applying the model to the whole international series, it appears that the highest risk concerns individuals with P9D9 non-Asp 57 and both the charged P4 of DRB1 and P4 of DQB1, conferring a 80% prediction of susceptibility. Conversely, P9DQ Asp and neutral P4DQ and P4DQ give the low est risk with a predictive value of 5%. This model of risk susceptibility prediction fits remarkably well with the observed distribution in a worldwide study. It allows a better evaluation of the respective role of HLA-DR and -DQ molecules as a major component of susceptibility to IDDM.
引用
收藏
页码:341 / 348
页数:8
相关论文
共 28 条
[1]   A HYPOTHETICAL MODEL OF THE FOREIGN ANTIGEN-BINDING SITE OF CLASS-II HISTOCOMPATIBILITY MOLECULES [J].
BROWN, JH ;
JARDETZKY, T ;
SAPER, MA ;
SAMRAOUI, B ;
BJORKMAN, PJ ;
WILEY, DC .
NATURE, 1988, 332 (6167) :845-850
[2]   AGE-DEPENDENT HLA GENETIC-HETEROGENEITY OF TYPE-1 INSULIN-DEPENDENT DIABETES-MELLITUS [J].
CAILLATZUCMAN, S ;
GARCHON, HJ ;
TIMSIT, J ;
ASSAN, R ;
BOITARD, C ;
DJILALISAIAH, I ;
BOUGNERES, P ;
BACH, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (06) :2242-2250
[3]  
CAILLATZUCMAN S, 1997, GENETIC DIVERSITY HL, V1, P389
[4]   Strong association between DQA1/DQB1 genotype and early-onset IDDM in Chinese: the association is with alleles rather than specific residues [J].
Chang, YW ;
Lam, KSL ;
Hawkins, BR .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1998, 25 (04) :273-280
[5]   A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes [J].
Conrad, B ;
Weissmahr, RN ;
Boni, J ;
Arcari, R ;
Schupbach, J ;
Mach, B .
CELL, 1997, 90 (02) :303-313
[6]   A GENOME-WIDE SEARCH FOR HUMAN TYPE-1 DIABETES SUSCEPTIBILITY GENES [J].
DAVIES, JL ;
KAWAGUCHI, Y ;
BENNETT, ST ;
COPEMAN, JB ;
CORDELL, HJ ;
PRITCHARD, LE ;
REED, PW ;
GOUGH, SCL ;
JENKINS, SC ;
PALMER, SM ;
BALFOUR, KM ;
ROWE, BR ;
FARRALL, M ;
BARNETT, AH ;
BAIN, SC ;
TODD, JA .
NATURE, 1994, 371 (6493) :130-136
[7]  
Delepine M, 1997, AM J HUM GENET, V60, P174
[8]  
DESCHAMPS I, 1986, DIABETES RES CLIN EX, V3, P391
[9]   LIFE TABLE ANALYSIS OF THE RISK OF TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS IN SIBLINGS ACCORDING TO ISLET CELL ANTIBODIES AND HLA MARKERS - AN 8-YEAR PROSPECTIVE-STUDY [J].
DESCHAMPS, I ;
BOITARD, C ;
HORS, J ;
BUSSON, M ;
MARCELLIBARGE, A ;
MOGENET, A ;
ROBERT, JJ .
DIABETOLOGIA, 1992, 35 (10) :951-957
[10]  
DESCHAMPS I, 1983, DIABETES METAB, V9, P259